The inspection, which took place from September 18 to 25, covered both the allergy immunotherapy facility and the contract manufacturing facility. Shares of Jubilant Pharmova Ltd ended at ₹1,183.90, down by ₹25.75, or 2.13%, on the BSE.
The inspection, which took place from September 18 to 25, covered both the allergy immunotherapy facility and the contract manufacturing facility. Shares of Jubilant Pharmova Ltd ended at ₹1,183.90, down by ₹25.75, or 2.13%, on the BSE.